Efficacy of Bifidobacterium Breve fermented milk in maintaining remission of ulcerative colitis: Randomized placebo-controlled trial - B-FLORA

Public Health Research foundation0 个研究点目标入组 195 人开始时间: 2012年4月2日最近更新: 2023年10月17日

适应症

试验速览

•(1)Patients who are diagnoised as proktitis by endoscope in nearly the day of entering this study (2)experienced bloody-stool in 4 weeks before that day (3)changed doses of oral 5ASA therapy or changed to another blands in 4 weeks before that day (4)started rectal 5ASA or adrenocorticoid therapy in 4 weeks before that day (5)started oral or parenteral adrenocorticoid therapy in 4 weeks before that day (6)started LCAP or GCAP therapy in 4 weeks before that day (7)started immunomodulator therapy in 12 weeks before that day (8)started immunosuppressant therapy in 12 weeks before that day (9)started targeted therapy in 12 weeks before that day (10)use antubiotics for over 14 days in 4 weeks before that day (11)can not stop to take another probiotics during this study (12)take reguraly the same probiotics as the test sample in 10 days before that day (13)register another clinical trials (14)experienced colon excision (15)experienced hypersensitivities to proviotics (16)having serious hepatic or kidney disorder (17)having mental disorder obviously (18)having malignant tumor or experienced in 5 years before that day (19)female who are pregnant, possible to be pregnant or want to be (20)judged to be exclusive by investigators with another reason

发起方